View in EDS

Discontinuing Long-Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?

Saved in:
Bibliographic Details
Title: Discontinuing Long-Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?
Authors: Lu KH; Department of Orthopedics, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan., Lin RC; Department of Orthopedics, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan., Chang IL; Department of Orthopaedic Surgery, Changhua Christian Hospital, Changhua, Taiwan., Fu SH; Department of Orthopedics, National Taiwan University Hospital Yun-Lin Branch, Douliu, Taiwan., Tsai MY; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan., Yang SF; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2026 Aug; Vol. 120 (2), pp. 334-344. Date of Electronic Publication: 2026 May 08.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-6535
DOI:10.1002/cpt.70323